Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
The newly emerged pandemic coronavirus, SARS-CoV-2, has posed a significant public health threat worldwide. However, the mode of virus transmission and tissue tropism is not well established yet. Recent findings of substantial liver damage in patients and ACE2+ cholangiocytes in healthy liver tissues prompted us to hypothesize that human liver ductal organoids could serve as a model to determine the susceptibility and mechanisms underlining the liver damage upon SARS-CoV-2 infection. By single-cell RNA sequencing, we found that long-term liver ductal organoid culture preserved the human specific ACE2+ population of cholangiocytes. Moreover, human liver ductal organoids were permissive to SARS-CoV-2 infection and support robust replication. Notably, virus infection impaired the barrier and bile acid transporting functions of cholangiocytes through dysregulation of genes involved in tight junction formation and bile acid transportation, which could explain the bile acid accumulation and consequent liver damage in patients. These results indicate that control of liver damage caused directly by viral infection should be valued in treating COVID-19 patients. Our findings also provide an application of human organoids in investigating the tropism and pathogenesis of SARS-CoV-2, which would facilitate novel drug discovery.
Article activity feed
-
SciScore for 10.1101/2020.03.16.990317: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources The following antibodies were used: rabbit anti-ACE2 (Sino Biological Inc, 10108-RP01, 1:100), rabbit anti-SARS-CoV-2 N protein (Rockland, 200-401-A50, anti-ACE2suggested: (Enzo Life Sciences Cat# ALX-804-722-C100, RRID:AB_11180102)anti-SARS-CoV-2 N proteinsuggested: NoneExperimental Models: Cell Lines Sentences Resources Virus was plaque-purified, propagated in Vero-E6 cells, and stored at –80°C for use. Vero-E6suggested: None… SciScore for 10.1101/2020.03.16.990317: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources The following antibodies were used: rabbit anti-ACE2 (Sino Biological Inc, 10108-RP01, 1:100), rabbit anti-SARS-CoV-2 N protein (Rockland, 200-401-A50, anti-ACE2suggested: (Enzo Life Sciences Cat# ALX-804-722-C100, RRID:AB_11180102)anti-SARS-CoV-2 N proteinsuggested: NoneExperimental Models: Cell Lines Sentences Resources Virus was plaque-purified, propagated in Vero-E6 cells, and stored at –80°C for use. Vero-E6suggested: NoneExperimental Models: Organisms/Strains Sentences Resources Mouse primary liver ductal organoids were cultured from biliary ducts isolated from an 8-week-old C57BL/6 mouse. C57BL/6suggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on page 17. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
